Literature DB >> 32706044

MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1.

Y-P Wang1, J Liu, D Liu, X-D Wang, A-M Bian, D-Z Fang, X-B Hui.   

Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1, by Y.-P. Wang, J. Liu, D. Liu, X.-D. Wang, A.-M. Bian, D.-Z. Fang, X.-B. Hui, published in Eur Rev Med Pharmacol Sci 2019; 23 (20): 8964-8970-DOI: 10.26355/eurrev_201910_19295-PMID: 31696484" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19295.

Entities:  

Year:  2020        PMID: 32706044     DOI: 10.26355/eurrev_202007_21856

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.

Authors:  Xi Chen; Jishu Guo; Fan Zhou; Wenjun Ren; Xiaobin Huang; Jun Pu; Xiaoqun Niu; Xiulin Jiang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  MicroRNA-532-5p protects against cerebral ischemia-reperfusion injury by directly targeting CXCL1.

Authors:  Yuanyuan Shi; Zhongquan Yi; Panwen Zhao; Yun Xu; Pinglei Pan
Journal:  Aging (Albany NY)       Date:  2021-04-18       Impact factor: 5.682

3.  lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.

Authors:  Yi Peng; Xiaoxi Huang; Hongmei Wang
Journal:  BMC Mol Cell Biol       Date:  2022-07-27

4.  RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.

Authors:  Yi Li; Ning-Xi Wang; Chuan Yin; Shan-Shan Jiang; Jia-Chu Li; Sheng-Yong Yang
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.